Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000455299 | SCV000538277 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000455299 | SCV001339094 | uncertain significance | not specified | 2020-03-30 | criteria provided, single submitter | clinical testing | Variant summary: ALMS1 c.75_80delAGAGGA (p.Glu27_Glu28del) results in an in-frame deletion that is predicted to remove two amino acids from the encoded protein. The variant was absent in 127964 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.75_80delAGAGGA in individuals affected with Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as benign. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Labcorp Genetics |
RCV002526375 | SCV003022612 | likely benign | Alstrom syndrome | 2025-01-06 | criteria provided, single submitter | clinical testing |